Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Ipsen Biopharm Ltd is seeking a Country Cluster Head for Western Europe. The role leads Ipsen’s country operations and oversees site management, monitoring, and governance within a Functional Service Provider delivery model.
The position demands strategic thinking, cross-functional leadership, and strong collaboration with global and local stakeholders to ensure compliant, high‑quality trial delivery across the region.
CDO Country Cluster Head - Western Europe/Remote
Ipsen Biopharm Ltd
Ipsen is a mid‑sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Supported by nearly 100 years of development experience, with global hubs in the U.S., France and the U.K, we tackle areas of high unmet medical need through research and innovation.
Our passionate teams in more than 40 countries are focused on what matters and endeavor every day to bring medicines to patients in 88 countries. We build a workplace that champions human‑centric leadership and fosters a culture of collaboration, excellence and impact. At Ipsen, every individual is empowered to be their true selves, grow and thrive alongside the company's success. Join us on our journey towards sustainable growth, creating real impact on patients and society!
For more information, visit us at https://www.ipsen.com/ and follow our latest news on LinkedIn and Instagram .
Job Advertisement
The Country‑Cluster Lead is a leadership role, reporting to the Head of Study, Site Management and Monitoring (SSMM) within Clinical Development Operations, accountable for the oversight and operational excellence of Ipsen's Country Operations activities under a Functional Service Provider (FSP) delivery model. The role provides leadership across the clinical trial lifecycle at country and site level, from feasibility and site selection through study start‑up, site management, monitoring (inc Risk Based), study close‑out, and inspection readiness.
The role ensures consistent, compliant, and high‑quality execution at country level IPSEN studies in the CDO portfolio and will be accountable for governance, and oversight of FSP partners delivering country and site‑level activities on Ipsen's behalf. The individual will require a 'Think Local, Act Global' mindset understanding local needs, within their Country/Cluster, but an ability to think strategically and to align globally.
The role is accountable for ensuring high‑performing sites, reliable data, and effective, best in class investigator relationships across Ipsen's global portfolio. Acts as single point of accountability for country/cluster level performance.
The Country‑Cluster Lead manages IPSEN staff, operating within that Cluster including Functional Managers, Cluster Trial Managers and Principal Clinical Research Associates. They also collaborate closely with FSP Leadership and Staff in their Cluster/Country.
Partner with functional leaders and FSP partners to ensure clinical trials are delivered on time, within budget, and in‑line with Quality standards.
Overall accountability for country(s) project delivery to agreed timelines, including patient recruitment targets.
Build, develop and motivate a high‑performing internal team and ensure FSP providers are bringing the right resource on board to ensure overall delivery.
Drive continuous improvement of Clinical Operations processes and procedures to optimise development speed, quality, quality and regulatory compliance
Provide end‑to‑end oversight of FSP partners delivering:
In collaboration with appropriate global functions, establish strategic, data‑driven approaches to country feasibility and site selection, ensuring optimal country and site choices.
Oversee site feasibility execution and validation to support realistic enrolment projections and operational planning.
Ensure efficient, compliant study start‑up execution, including:
Monitor start‑up performance metrics and proactively address delays or bottlenecks
I